Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an update.
Guangzhou Baiyunshan Pharmaceutical Holdings has announced that the term of its ninth board is ending and that shareholders will vote on a new, tenth board at the 2025 annual general meeting. The proposed board will comprise eleven directors, including ten non‑employee representatives and one employee representative elected separately by staff.
The company has nominated ten director candidates, combining reappointments of existing executive and independent non‑executive directors with several new nominees. It emphasized that candidates meet Hong Kong listing rules on independence and disclosure, and, if approved, each director will serve a three‑year term, underscoring a focus on governance continuity and regulatory compliance.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a Chinese joint stock company listed in Hong Kong that operates in the pharmaceutical industry. The group focuses on manufacturing and distributing medicines and related healthcare products, serving domestic and international markets through its diversified portfolio and established brands.
Average Trading Volume: 1,261,587
Technical Sentiment Signal: Sell
Current Market Cap: HK$40.41B
For a thorough assessment of 0874 stock, go to TipRanks’ Stock Analysis page.